Lance Berberian Laboratory Corp Of America Holdings (LH) insider trading activity

Lance Berberian is EVP, CIO & CTO of LABORATORY CORP OF AMERICA HOLDINGS. Currently has a direct ownership of 15,921 shares of LH, which is worth approximately $3.62 Million. The most recent transaction as insider was on Aug 05, 2024, when has been sold 12,093 shares (Common Stock) at a price of $229.36 per share, resulting in proceeds of $2,773,650. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.9K

43.17% 3M change

30.41% 12M change

Total Value Held $3.62 Million

LANCE BERBERIAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 05 2024	SELL Open market or private sale	$2,773,650 $229.36 p/Share	12,093 Reduced 43.17%	15,921 Common Stock
Mar 27 2024	SELL Payment of exercise price or tax liability	$714,464 $216.57 p/Share	3,299 Reduced 10.54%	28,014 Common Stock
Mar 27 2024	BUY Exercise of conversion of derivative security	-	7,697 Added 19.73%	31,313 Common Stock
Feb 12 2024	SELL Payment of exercise price or tax liability	$19,788 $227.45 p/Share	87 Reduced 0.37%	23,616 Common Stock
Feb 11 2024	BUY Exercise of conversion of derivative security	-	324 Added 1.35%	23,703 Common Stock
Feb 07 2024	SELL Payment of exercise price or tax liability	$21,028 $223.71 p/Share	94 Reduced 0.4%	23,379 Common Stock
Feb 07 2024	BUY Exercise of conversion of derivative security	-	353 Added 1.48%	23,473 Common Stock
Feb 02 2024	SELL Payment of exercise price or tax liability	$19,717 $221.54 p/Share	89 Reduced 0.38%	23,120 Common Stock
Feb 02 2024	BUY Exercise of conversion of derivative security	-	331 Added 1.41%	23,209 Common Stock
Mar 30 2023	SELL Payment of exercise price or tax liability	$404,235 $224.7 p/Share	1,799 Reduced 7.29%	22,878 Common Stock
Mar 30 2023	BUY Grant, award, or other acquisition	-	4,509 Added 15.45%	24,677 Common Stock
Feb 13 2023	SELL Payment of exercise price or tax liability	$21,091 $248.13 p/Share	85 Reduced 0.42%	20,168 Common Stock
Feb 11 2023	BUY Exercise of conversion of derivative security	-	290 Added 1.41%	20,253 Common Stock
Feb 06 2023	SELL Payment of exercise price or tax liability	$26,406 $244.5 p/Share	108 Reduced 0.54%	19,963 Common Stock
Feb 04 2023	BUY Exercise of conversion of derivative security	-	374 Added 1.83%	20,071 Common Stock
Feb 02 2023	SELL Payment of exercise price or tax liability	$26,008 $254.99 p/Share	102 Reduced 0.52%	19,697 Common Stock
Feb 02 2023	BUY Exercise of conversion of derivative security	-	297 Added 1.48%	19,799 Common Stock
Mar 28 2022	SELL Payment of exercise price or tax liability	$652,351 $276.42 p/Share	2,360 Reduced 10.79%	19,502 Common Stock
Mar 27 2022	BUY Grant, award, or other acquisition	-	5,310 Added 19.54%	21,862 Common Stock
Feb 14 2022	SELL Payment of exercise price or tax liability	$217,871 $272.68 p/Share	799 Reduced 4.6%	16,552 Common Stock
Feb 12 2022	BUY Exercise of conversion of derivative security	-	2,708 Added 13.5%	17,351 Common Stock
Feb 04 2022	SELL Payment of exercise price or tax liability	$30,245 $277.48 p/Share	109 Reduced 0.74%	14,643 Common Stock
Feb 04 2022	BUY Exercise of conversion of derivative security	-	373 Added 2.47%	14,752 Common Stock
Feb 02 2022	SELL Payment of exercise price or tax liability	$28,138 $273.18 p/Share	103 Reduced 0.71%	14,379 Common Stock
Feb 02 2022	BUY Exercise of conversion of derivative security	-	296 Added 2.0%	14,482 Common Stock

Lance Berberian

EVP, CIO & CTO

Burlington, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LH shares.

Notify only if

Value

Insider Trading

Get notified when an Laboratory Corp Of America Holdings insider buys or sells LH shares.

Notify only if

Operation

Value

Type

News

Receive news related to LABORATORY CORP OF AMERICA HOLDINGS

Track Activities on LH

Account